A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern iran

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Aflatoonian, Mohammad Reza ^a   Sharifi, Iraj ^b   Parizi, Maryam Hakimi ^b   Fekri, Ali Reza ^b   Aflatoonian, Behnaz ^c   Sharifi, Maryam ^d   Khosravi, Ahmad ^b   Khamesipour, Ali ^e   Sharifi, Hamid ^f,g  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; IRAN; LEISHMANIA TROPICA; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; OPIATE ADDICTION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RISK FACTOR; SKIN LEISHMANIASIS; ADOLESCENT; COMPLICATION; KAPLAN MEIER METHOD; LEISHMANIASIS, CUTANEOUS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; FEMALE; HUMANS; IRAN; KAPLAN-MEIER ESTIMATE; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84895857449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089043     Document Type: Article

References (36)

1. United Nations Office on Drugs and Crime website. Available: www.unodc.org/documents/data-and-analysis/WDR2011/WDR2011-web.pdf. Accessed 2011 October 4.
2. United Nations Office on Drugs and Crime website. Available: http://www.unodc.org/documents/data-and-analysis/Studies/Afghan-Drug-Survey- 2009-Executive-Summary-web.pdf. Accessed 2011 October 12.
3. United Nations (2003) Global illicit drug trends: Pretoria: UNODC New York. 101-136.
4. United Nations Office on Drugs and Crime website. Available: http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR-2012-web- small.pdf. Accessed 2012 August 22.
5. Farnia M, Ebrahimi B, Shams A & Zamani S (2010) Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Inter J Drug Policy21: 422-4.
6. World Health Organization (WHO) (2010) Control of the leishmaniases. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, WHO Technical Report Series 949, Geneva. 1-187.
7. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
8. Ashford RW (2000) The leishmaniasis as emerging and re-emerging zoonoses. Inter J Parasitol 30: 1269-1281.
9. Nadim A, Aflatoonian MR (1995) Anthroponotic cutaneous leishmaniasis in Bam, southeast Iran. Iran J Public Health 24: 15-24.
10. Shirzadi MR, Gouya MM (2010) National Guidelines for cutaneous leishmaniasis surveillance in Iran, M.o.H.a.M.E. Zoonoses Control Department, Tehran, I.R. Iran, 1-78.
11. Desjeux P (2001) The increase in risk factors for the leishmaniasis worldwide. Tran Roy Soc Trop Med Hyg 95: 239-43.
12. Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19: 11-26.
13. Sharifi I, Nakhaei N, Aflatoonian MR, Hakimi Parizi M, Fekri AR, et al (2011) Cutaneous leishmaniasis in Bam: A comparative evaluation of pre- and post-earthquake years (1999-2008). Iranian J Publ Health 40: 49-56.
14. Seyedin SH, Aflatoonian MR, Ryan J (2009) Adverse impact of international NGOs during and after the Bam earthquake: health system's consumers' points of view. Am J Disaster Med 4(3): 173-9.
15. Montazeri A, Baradaran H, Omidvari S, Azin SA, Ebadi M, et al (2005) Psychological distress among Bam earthquake survivors in Iran: a population-based study. BMC Public Health 11: 4.
16. Mc Quay H (1999) Opioids in pain management. Lancet 353: 2229-32.
17. Ahmadi J, Pridmore S, Alimi A, Cheraghi A, Arad A, et al (2007) Epidemiology of opium use in the general population. Am J Drug Alcohol Abuse 33: 483-91. (Pubitemid 47037169)
18. Aflatoonian MR, Meymandi MS, Divsalar K, Mahmoudi M, Heravi G (2011) Possible association between human blood types and opioid addiction. Am J Addict 20: 581-4.
19. Ziaaddini H, Ziaaddini MR (2005) The household survey of drug abuse in Kerman, Iran. J Applied Sci 5: 380-382.
20. Gilrame E (2000) Substance abuse in young people. J Child Psychol Psyc 41: 55280.
21. Sokal JE (1975) Editorial: Measurement of delayed skin-test responses. N Eng J Med 293: 501-502.
22. Noyes HA, Reyburn H, Bailey JW, Smith D (1998) A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan. J Clin Microbiol 36: 2877-81. (Pubitemid 28429408)
23. Postigo JA (2010) Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents36: 62-5.
24. Mousavi SS, Mahmoudi-gharaei J, Bina M, Gholampoor E, Eisar S (2006) Post traumatic stress disorder and general symptoms of anxiety in adolescent survivors of Bam earthquake. Iran J Psychiatry 1: 76-80.
25. Galea S, Ahern J, Resnick H, Kilpatrick D, Bucuvalas M, et al. (2002) Psychological squeal of the september 11 terrorist attacks in New York city. N Engl J Med 346: 982-987.
26. Sacerdote P, Manfredi B, Mantegazza P, Panerai AE (1997) Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol 121: 834-840. (Pubitemid 27260792)
27. Wei G, Moss J, Yuan CS (2003) Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? Biochem Pharmacol 65: 1761-6. (Pubitemid 36629501)
28. Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987) Opioid mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 138: 3907e12.
29. Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, et al. (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiol 83: 500e8.
30. Molitor TW, Morilla A, Risdahl JM, Murtaugh MP, Chao CC, et al. (1992) Chronic morphine administration impairs cell-mediated immune responses in swine. J Pharmacol Exp Ther 260: 581e6.
31. Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK (1992) Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol Immunotoxicol 14: 657e73.
32. Lysle DT, How T (2000) Heroin modulates the expression of inducible nitric oxide syntheses. Immunopharmacology 46: 181e92.
33. Singh PP, Singal P (2007) Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role (s) of cytokines and nitric oxide. J Neuroimmune Pharmacol 2: 338-351.
34. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK (1990) Lethality of morphine in mice infected with Toxoplasma gondii. J PharmacolExpTher252: 605-609. (Pubitemid 20101873)
35. Voukassovitch C (1986) [Drug addiction, anorexia: what is the connection?]. Ann Med Psychol 144: 695-709.
36. Guernaoui S, Boussaa S, Pesson B, Boumezzough A (2006) Nocturnal activity of phlebotomine sandflies (Diptera: Psychodidae) in a cutaneous leishmaniasis focus in Chichaoua, Morocco. Parasitol Res98(3): 184-8. (Pubitemid 43207306)